Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review BA Goldstein, AM Navar, MJ Pencina, JPA Ioannidis Journal of the American Medical Informatics Association: JAMIA 24 (1), 198, 2017 | 816 | 2017 |
Application of new cholesterol guidelines to a population-based sample MJ Pencina, AM Navar-Boggan, RB D'Agostino Sr, K Williams, B Neely, ... New England Journal of Medicine 370 (15), 1422-1431, 2014 | 757 | 2014 |
Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence SB Omer, WKY Pan, NA Halsey, S Stokley, LH Moulton, AM Navar, ... Jama 296 (14), 1757-1763, 2006 | 502 | 2006 |
Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges BA Goldstein, AM Navar, RE Carter European heart journal 38 (23), 1805-1814, 2017 | 461 | 2017 |
Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease AM Navar-Boggan, ED Peterson, RB D’Agostino Sr, B Neely, ... Circulation 131 (5), 451-458, 2015 | 408 | 2015 |
Apolipoprotein B particles and cardiovascular disease: a narrative review AD Sniderman, G Thanassoulis, T Glavinovic, AM Navar, M Pencina, ... JAMA cardiology 4 (12), 1287-1295, 2019 | 378 | 2019 |
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of … Writing Committee Members, SS Virani, LK Newby, SV Arnold, V Bittner, ... Journal of the American College of Cardiology 82 (9), 833-955, 2023 | 313 | 2023 |
Quantifying importance of major risk factors for coronary heart disease MJ Pencina, AM Navar, D Wojdyla, RJ Sanchez, I Khan, J Elassal, ... Circulation 139 (13), 1603-1611, 2019 | 215 | 2019 |
Effectiveness of measles vaccination and vitamin A treatment CR Sudfeld, AM Navar, NA Halsey International journal of epidemiology 39 (suppl_1), i48-i55, 2010 | 211 | 2010 |
Sex differences in the use of statins in community practice: patient and provider assessment of lipid management registry MG Nanna, TY Wang, Q Xiang, AC Goldberg, JG Robinson, VL Roger, ... Circulation: Cardiovascular Quality and Outcomes 12 (8), e005562, 2019 | 202 | 2019 |
Patient‐reported reasons for declining or discontinuing statin therapy: insights from the PALM registry CK Bradley, TY Wang, S Li, JG Robinson, VL Roger, AC Goldberg, ... Journal of the American Heart Association 8 (7), e011765, 2019 | 188 | 2019 |
Validation of the sleep regularity index in older adults and associations with cardiometabolic risk JR Lunsford-Avery, MM Engelhard, AM Navar, SH Kollins Scientific reports 8 (1), 14158, 2018 | 155 | 2018 |
Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review E Vynnycky, EJ Adams, FT Cutts, SE Reef, AM Navar, E Simons, ... PloS one 11 (3), e0149160, 2016 | 142 | 2016 |
Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel P Muntner, PT Einhorn, WC Cushman, PK Whelton, NA Bello, PE Drawz, ... Journal of the American College of Cardiology 73 (3), 317-335, 2019 | 139 | 2019 |
Association of vaccine-related attitudes and beliefs between parents and health care providers MJ Mergler, SB Omer, WKY Pan, AM Navar-Boggan, W Orenstein, ... Vaccine 31 (41), 4591-4595, 2013 | 137 | 2013 |
Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta‐analysis SH Yedlapati, SU Khan, S Talluri, AN Lone, MZ Khan, MS Khan, ... Journal of the American Heart Association 10 (6), e019636, 2021 | 136 | 2021 |
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the … A Khera, SJ Baum, TJ Gluckman, M Gulati, SS Martin, ED Michos, ... American journal of preventive cardiology 1, 100009, 2020 | 136 | 2020 |
Proportion of US adults potentially affected by the 2014 hypertension guideline AM Navar-Boggan, MJ Pencina, K Williams, AD Sniderman, ED Peterson Jama 311 (14), 1424-1429, 2014 | 125 | 2014 |
Association of prior authorization and out-of-pocket costs with patient access to PCSK9 inhibitor therapy AM Navar, B Taylor, H Mulder, E Fievitz, KL Monda, A Fievitz, JF Maya, ... JAMA cardiology 2 (11), 1217-1225, 2017 | 119 | 2017 |
Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and provider assessment … MG Nanna, AM Navar, P Zakroysky, Q Xiang, AC Goldberg, J Robinson, ... JAMA cardiology 3 (8), 739-748, 2018 | 106 | 2018 |